{"id":1778,"date":"2019-10-24T12:01:14","date_gmt":"2019-10-24T10:01:14","guid":{"rendered":"https:\/\/curamus-cancer.fr\/efficacite-et-tolerance-de-limmunotherapie-dans-le-traitement-de-patients-atteints-de-cancer-et-vivant-avec-le-vih\/"},"modified":"2020-05-10T13:38:54","modified_gmt":"2020-05-10T11:38:54","slug":"efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv","status":"publish","type":"post","link":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/","title":{"rendered":"Efficiency and tolerance of immunotherapy in the treatment of cancer patients living with HIV"},"content":{"rendered":"<p><strong>The French CANCERVIH network, coordinated by Prof. Jean-Philippe Spano of the Medical Oncology Department of the Piti\u00e9-Salp\u00eatri\u00e8re Hospital AP-HP and Sorbonne University, studied the efficacy and safety of immunotherapy on the world&#8217;s largest series of HIV-infected people with cancer treated in routine care (excluding clinical trials).<\/strong><\/p>\n<p><strong>The results, which show that the treatment is effective and well tolerated, represent a real advance in the management of HIV-infected patients with cancer.\u00a0 <a href=\"https:\/\/journals.lww.com\/aidsonline\/Abstract\/publishahead\/Immunotherapy_for_cancer_in_people_living_with.96894.aspx\">They were published on 26 June 2019 in the journal AIDS.<\/a><\/strong><\/p>\n<p>More information : <a href=\"https:\/\/www.aphp.fr\/contenu\/efficacite-et-tolerance-de-limmunotherapie-dans-le-traitement-de-patients-atteints-de-cancer\">https:\/\/www.aphp.fr\/contenu\/efficacite-et-tolerance-de-limmunotherapie-dans-le-traitement-de-patients-atteints-de-cancer<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong><u>Sources\u00a0:\u00a0<\/u><\/strong><\/p>\n<p><strong><em>Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience. <\/em><\/strong><\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Spano%20JP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Spano JP<\/a><sup>1<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Veyri%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Veyri M<\/a><sup>2<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Gobert%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Gobert A<\/a><sup>3<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Guihot%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Guihot A<\/a><sup>4<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Perr%C3%A9%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Perr\u00e9 P<\/a><sup>5<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Kerjouan%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Kerjouan M<\/a><sup>6<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Brosseau%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Brosseau S<\/a><sup>7<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Cloarec%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Cloarec N<\/a><sup>8<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Montaudie%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Montaudie H<\/a><sup>9<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Helissey%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Helissey C<\/a><sup>10<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Flament%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Flament T<\/a><sup>11<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Gounant%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Gounant V<\/a><sup>7<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Lavol%C3%A9%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Lavol\u00e9 A<\/a><sup>12<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Poizot-Martin%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Poizot-Martin I<\/a><sup>13<\/sup>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Katlama%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=31259762\">Katlama C<\/a><sup>14<\/sup>.<\/p>\n<p><a title=\"AIDS (London, England).\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31259762\">AIDS.<\/a> 2019 Jun 26. doi: 10.1097\/QAD.0000000000002298.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The French CANCERVIH network, coordinated by Prof. Jean-Philippe Spano of the Medical Oncology Department of the Piti\u00e9-Salp\u00eatri\u00e8re Hospital AP-HP and [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":1779,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[27],"tags":[],"class_list":["post-1778","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-leucemie-vulgarise-en-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Efficiency and tolerance of immunotherapy in the treatment of cancer patients living with HIV - Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Efficiency and tolerance of immunotherapy in the treatment of cancer patients living with HIV - Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer\" \/>\n<meta property=\"og:description\" content=\"The French CANCERVIH network, coordinated by Prof. Jean-Philippe Spano of the Medical Oncology Department of the Piti\u00e9-Salp\u00eatri\u00e8re Hospital AP-HP and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/\" \/>\n<meta property=\"og:site_name\" content=\"Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cancercuramus\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-24T10:01:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-05-10T11:38:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/10\/Cancer_immunotherapy_HIV_Spano-2019.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"703\" \/>\n\t<meta property=\"og:image:height\" content=\"345\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sarah L\u00e9vesque\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sarah L\u00e9vesque\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/\"},\"author\":{\"name\":\"Sarah L\u00e9vesque\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#\\\/schema\\\/person\\\/46844c50d4f01ec82bf18429533914ba\"},\"headline\":\"Efficiency and tolerance of immunotherapy in the treatment of cancer patients living with HIV\",\"datePublished\":\"2019-10-24T10:01:14+00:00\",\"dateModified\":\"2020-05-10T11:38:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/\"},\"wordCount\":161,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/curamus-cancer.fr\\\/wp-content\\\/uploads\\\/2019\\\/10\\\/Cancer_immunotherapy_HIV_Spano-2019.jpg\",\"articleSection\":[\"Leuc\u00e9mie vulgaris\u00e9\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/\",\"url\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/\",\"name\":\"Efficiency and tolerance of immunotherapy in the treatment of cancer patients living with HIV - Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/curamus-cancer.fr\\\/wp-content\\\/uploads\\\/2019\\\/10\\\/Cancer_immunotherapy_HIV_Spano-2019.jpg\",\"datePublished\":\"2019-10-24T10:01:14+00:00\",\"dateModified\":\"2020-05-10T11:38:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/#primaryimage\",\"url\":\"https:\\\/\\\/curamus-cancer.fr\\\/wp-content\\\/uploads\\\/2019\\\/10\\\/Cancer_immunotherapy_HIV_Spano-2019.jpg\",\"contentUrl\":\"https:\\\/\\\/curamus-cancer.fr\\\/wp-content\\\/uploads\\\/2019\\\/10\\\/Cancer_immunotherapy_HIV_Spano-2019.jpg\",\"width\":703,\"height\":345},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Efficiency and tolerance of immunotherapy in the treatment of cancer patients living with HIV\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/\",\"name\":\"Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer\",\"description\":\"Nous soignons et prenons soin\",\"publisher\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#organization\",\"name\":\"Siric Cancer - Curamus\",\"url\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/curamus-cancer.fr\\\/wp-content\\\/uploads\\\/2019\\\/07\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/curamus-cancer.fr\\\/wp-content\\\/uploads\\\/2019\\\/07\\\/logo.jpg\",\"width\":378,\"height\":113,\"caption\":\"Siric Cancer - Curamus\"},\"image\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/cancercuramus\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#\\\/schema\\\/person\\\/46844c50d4f01ec82bf18429533914ba\",\"name\":\"Sarah L\u00e9vesque\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75f6e3dbd3ebff42c299d2b19140d03103ee7d2882d305677fe0c8ae94cccbe5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75f6e3dbd3ebff42c299d2b19140d03103ee7d2882d305677fe0c8ae94cccbe5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75f6e3dbd3ebff42c299d2b19140d03103ee7d2882d305677fe0c8ae94cccbe5?s=96&d=mm&r=g\",\"caption\":\"Sarah L\u00e9vesque\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Efficiency and tolerance of immunotherapy in the treatment of cancer patients living with HIV - Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/","og_locale":"en_US","og_type":"article","og_title":"Efficiency and tolerance of immunotherapy in the treatment of cancer patients living with HIV - Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer","og_description":"The French CANCERVIH network, coordinated by Prof. Jean-Philippe Spano of the Medical Oncology Department of the Piti\u00e9-Salp\u00eatri\u00e8re Hospital AP-HP and [&hellip;]","og_url":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/","og_site_name":"Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer","article_publisher":"https:\/\/www.facebook.com\/cancercuramus\/","article_published_time":"2019-10-24T10:01:14+00:00","article_modified_time":"2020-05-10T11:38:54+00:00","og_image":[{"width":703,"height":345,"url":"https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/10\/Cancer_immunotherapy_HIV_Spano-2019.jpg","type":"image\/jpeg"}],"author":"Sarah L\u00e9vesque","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Sarah L\u00e9vesque","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/#article","isPartOf":{"@id":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/"},"author":{"name":"Sarah L\u00e9vesque","@id":"https:\/\/curamus-cancer.fr\/en\/#\/schema\/person\/46844c50d4f01ec82bf18429533914ba"},"headline":"Efficiency and tolerance of immunotherapy in the treatment of cancer patients living with HIV","datePublished":"2019-10-24T10:01:14+00:00","dateModified":"2020-05-10T11:38:54+00:00","mainEntityOfPage":{"@id":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/"},"wordCount":161,"commentCount":0,"publisher":{"@id":"https:\/\/curamus-cancer.fr\/en\/#organization"},"image":{"@id":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/#primaryimage"},"thumbnailUrl":"https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/10\/Cancer_immunotherapy_HIV_Spano-2019.jpg","articleSection":["Leuc\u00e9mie vulgaris\u00e9"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/","url":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/","name":"Efficiency and tolerance of immunotherapy in the treatment of cancer patients living with HIV - Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer","isPartOf":{"@id":"https:\/\/curamus-cancer.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/#primaryimage"},"image":{"@id":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/#primaryimage"},"thumbnailUrl":"https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/10\/Cancer_immunotherapy_HIV_Spano-2019.jpg","datePublished":"2019-10-24T10:01:14+00:00","dateModified":"2020-05-10T11:38:54+00:00","breadcrumb":{"@id":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/#primaryimage","url":"https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/10\/Cancer_immunotherapy_HIV_Spano-2019.jpg","contentUrl":"https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/10\/Cancer_immunotherapy_HIV_Spano-2019.jpg","width":703,"height":345},{"@type":"BreadcrumbList","@id":"https:\/\/curamus-cancer.fr\/en\/efficiency-and-tolerance-of-immunotherapy-in-the-treatment-of-cancer-patients-living-with-hiv\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/curamus-cancer.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Efficiency and tolerance of immunotherapy in the treatment of cancer patients living with HIV"}]},{"@type":"WebSite","@id":"https:\/\/curamus-cancer.fr\/en\/#website","url":"https:\/\/curamus-cancer.fr\/en\/","name":"Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer","description":"Nous soignons et prenons soin","publisher":{"@id":"https:\/\/curamus-cancer.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/curamus-cancer.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/curamus-cancer.fr\/en\/#organization","name":"Siric Cancer - Curamus","url":"https:\/\/curamus-cancer.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/curamus-cancer.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/07\/logo.jpg","contentUrl":"https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/07\/logo.jpg","width":378,"height":113,"caption":"Siric Cancer - Curamus"},"image":{"@id":"https:\/\/curamus-cancer.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cancercuramus\/"]},{"@type":"Person","@id":"https:\/\/curamus-cancer.fr\/en\/#\/schema\/person\/46844c50d4f01ec82bf18429533914ba","name":"Sarah L\u00e9vesque","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/75f6e3dbd3ebff42c299d2b19140d03103ee7d2882d305677fe0c8ae94cccbe5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/75f6e3dbd3ebff42c299d2b19140d03103ee7d2882d305677fe0c8ae94cccbe5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/75f6e3dbd3ebff42c299d2b19140d03103ee7d2882d305677fe0c8ae94cccbe5?s=96&d=mm&r=g","caption":"Sarah L\u00e9vesque"}}]}},"_links":{"self":[{"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/posts\/1778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/comments?post=1778"}],"version-history":[{"count":0,"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/posts\/1778\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/media\/1779"}],"wp:attachment":[{"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/media?parent=1778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/categories?post=1778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/tags?post=1778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}